The European Commission has routinely considered potential harm to innovation as part of its merger assessments, particularly in R&D driven sectors such as pharmaceuticals and technology. In recent years, however, the...more
3/22/2018
/ Bayer ,
Dow Chemical ,
DuPont ,
EU ,
European Commission ,
Horizontal Mergers ,
Innovation ,
Mergers ,
Monsanto ,
Popular ,
Research and Development
On September 7, 2017, the European Court of Justice (ECJ) decided that, where joint control is acquired over a new or existing undertaking (or parts of an undertaking), that transaction can only fall within the scope of the...more